SOLICITATION NOTICE
A -- Pre-Announcement: Prototype Solutions for Optic Nerve Injury - Pre-Announcement
- Notice Date
- 1/23/2018
- Notice Type
- Presolicitation
- NAICS
- 54171
— Research and Development in the Physical, Engineering, and Life SciencesT
- Contracting Office
- Department of the Army, U.S. Army Medical Research Acquisition Activity, U.S. Army Medical Research Acquisition Activity, Attn: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014, Maryland, 21702-5014, United States
- ZIP Code
- 21702-5014
- Solicitation Number
- MTEC-
- Archive Date
- 3/2/2018
- Point of Contact
- Lisa A. Fisher, Phone: 843-760-3356
- E-Mail Address
-
lisa.fisher@ati.org
(lisa.fisher@ati.org)
- Small Business Set-Aside
- N/A
- Description
- pdf copy of FBO posting for Pre-Announcement The Medical Technology Enterprise Consortium (MTEC) is excited to post this pre-announcement for a Request for Project Proposals (RPP) focused on providing innovative solutions to critical problems in visual loss. The overarching goal of this program is to provide biomanufacturing or advanced development for an emerging area of medical technology and innovation that supports standard procedures toward a prototype aimed to re-establish or regenerate damaged visual pathways. Technology Focus Areas Applications must address one or more of the following focus areas in nerve regeneration or end-organ health. Specifically, MTEC seeks prototype development and/or biomanufacturing of a device, biologic, or combination prototype that: • Enhances optic nerve regeneration • Re-establishes neuronal connections between retinal ganglion cells and the lateral geniculate nucleus with high efficiency The current effort aims to promote highly innovative, groundbreaking research; high-impact research with near-term clinical relevance; multidisciplinary, synergistic research; and translational studies to support the fluid transfer of knowledge from basic principles to clinical solutions. Purely in vitro efforts will not be considered. Proposed projects must be based on logical reasoning and sound scientific rationale that spread biomanufacturing and prototype development. Please note that awards are not to be exploratory in nature and require a foundation of preliminary data. Research involving animal or human subjects is allowed. Potential Funding Availability Potential funding available for awards made from this Funding Opportunity is $6.0 Million. Potential funds will be made available by the U.S. Government, Glaucoma Research Foundation, and BrightFocus Foundation. Funds are intended to support areas of regenerative medicine manufacturing and prototyping that require development and harmonization into reproducible, consistent procedures which could stand the test of U.S. Food and Drug Administration (FDA) approval. MTEC intends to make one or two awards at $3.0M each (direct and indirect costs) composed of teaming arrangements demonstrated to achieve the prototype development and manufacturing standardization. The Period of Performance (POP) is not to exceed 36 months. Acquisition Approach This RPP will be conducted using a two-staged approach. In Stage 1, current MTEC members are invited to submit White Papers using the format contained in the RPP (this posting is forthcoming). The Government, Glaucoma Research Foundation, and BrightFocus Foundation will evaluate White Papers submitted and will select White Papers that best meet their current technology priorities using the criteria specified in the RPP. Offerors whose technology solution is selected for further consideration based on White Paper evaluation will be invited to submit a proposal in Stage 2. Notification letters will contain specific Stage 2 proposal submission requirements. Other Information The MTEC mission is to assist the U.S. Army Medical Research and Materiel Command (USAMRMC) by providing cutting-edge technologies and effective materiel life cycle management to transition medical solutions to industry that protect, treat, and optimize Warfighters' health and performance across the full spectrum of military operations. MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement (OTA), Agreement No. W81XWH-15-9-0001, with the U.S. Army Medical Research Acquisition Activity (USAMRAA). MTEC is currently recruiting a broad and diverse membership that includes representatives from large businesses, small businesses, "nontraditional" government contractors, academic research institutions and not-for-profit organizations. Under a Non-Disclosure Agreement (NDA), Glaucoma Research Foundation and BrightFocus Foundation will have access to white papers and proposals submitted through this RPP for the purposes of the evaluation and selection process. The RPP will be posted to the MTEC website and FedBizOpps.gov to notify interested parties. MTEC membership is required for the submission of a white paper in response to this upcoming MTEC RPP. To join MTEC, please visit http://mtec-sc.org/how-to-join/ For inquiries regarding this pre-announcement, please direct your correspondence to the following contacts: • Technical questions - Dr. Lauren Palestrini, MTEC Director of Research, lauren.palestrini@officer.mtec-sc.org • Administrative questions - Ms. Polly Graham, Acting MTEC Program Manager, polly.graham@ati.org • Membership questions - Ms. Stacey Lindbergh, MTEC Executive Director, execdirect@mtec-sc.org
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/MTEC-/listing.html)
- Place of Performance
- Address: U.S. Army Medical Research Acquisition Activity, United States
- Record
- SN04796582-W 20180125/180123231013-343547984236875a74f1337477ebbf2a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |